We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+10.77%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$19.5B
AUM Growth
+$4.2B
(+27%)
Cap. Flow
+$3.06B
Cap. Flow
% of AUM
15.66%
Top 10 Holdings %
Top 10 Hldgs %
15.97%
Holding
1,184
New
406
Increased
253
Reduced
226
Closed
288
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$284M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
| 3 |
Eli Lilly
LLY
|
+$204M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Microsoft
MSFT
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$205M |
| 2 |
Merck
MRK
|
+$169M |
| 3 |
Canadian National Railway
CNI
|
+$131M |
| 4 |
NXP Semiconductors
NXPI
|
+$119M |
| 5 |
Fidelity National Information Services
FIS
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.23% |
| 2 | Technology | 20.39% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 8.95% |
| 5 | Communication Services | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
L3Harris
LHX
$51.6B
| $28.2M | 0.14% |
165,818
+163,460
| +6,932% | +$28.7M |
|
202
Electronic Arts
EA
$53B
| $27.7M | 0.14% |
212,528
-435,230
| -67% | -$59.3M |
|
203
Radian Group
RDN
$5.18B
| $27.2M | 0.14% |
1,859,857
+404,071
| +28% | +$6.02M |
|
204
Lamb Weston
LW
$7.22B
| $27.1M | 0.14% |
408,899
+252,783
| +162% | +$16.2M |
|
205
Procter & Gamble
PG
$336B
| $27.1M | 0.14% |
194,934
-160,862
| -45% | -$21.4M |
|
|
AXNX
206
DELISTED
Axonics, Inc. Common Stock
AXNX
| $27.1M | 0.14% |
530,819
+31,248
| +6% | +$1.3M |
|
207
Dover
DOV
$27.6B
| $27.1M | 0.14% |
250,000
+139,400
| +126% | +$14.9M |
|
208
CALL
Elevance Health
ELV
$81.5B
| $26.9M | 0.14% |
+100,000
| New | +$26.9M |
|
|
RDS.B
209
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $26.7M | 0.14% |
+1,103,238
| New | +$31.6M |
|
210
AstraZeneca
AZN
$263B
| $26.6M | 0.14% |
242,241
-105,453
| -30% | -$11.7M |
|
211
Baker Hughes
BKR
$60B
| $26.5M | 0.14% |
+1,997,135
| New | +$30.5M |
|
212
Exelixis
EXEL
$13.3B
| $26.4M | 0.14% |
1,078,341
+687,027
| +176% | +$16M |
|
|
BCYC
213
Bicycle Therapeutics
BCYC
$269M
| $26M | 0.13% |
1,363,151
+962,652
| +240% | +$17M |
|
214
LyondellBasell Industries
LYB
$20B
| $25.6M | 0.13% |
+363,886
| New | +$25.1M |
|
|
NGM
215
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $25.6M | 0.13% |
1,611,850
+88,265
| +6% | +$1.61M |
|
216
Capri Holdings
CPRI
$1.83B
| $25.6M | 0.13% |
+1,424,157
| New | +$24.2M |
|
217
Dave & Buster's
PLAY
$377M
| $25.6M | 0.13% |
1,687,502
+927,171
| +122% | +$13.7M |
|
|
IMMU
218
DELISTED
Immunomedics Inc
IMMU
| $25.5M | 0.13% |
300,000
-4,057,664
| -93% | -$205M |
|
219
Teck Resources
TECK
$29.6B
| $25.5M | 0.13% |
1,829,222
+1,180,422
| +182% | +$14M |
|
220
Glaukos
GKOS
$9.83B
| $25.3M | 0.13% |
+510,315
| New | +$22.4M |
|
221
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $25.2M | 0.13% |
686,860
| – | – |
|
222
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $25.1M | 0.13% |
456,327
| – | – |
|
223
Bread Financial
BFH
$4.37B
| $25M | 0.13% |
746,717
-28,570
| -4% | -$1.02M |
|
224
Owens Corning
OC
$11.2B
| $24.9M | 0.13% |
362,299
+161,496
| +80% | +$10.4M |
|
|
SAIL
225
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $24.9M | 0.13% |
629,633
-2,593,311
| -80% | -$90.1M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, Point72 Asset Management held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Point72 Asset Management deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.
- Point72 Asset Management's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
- Point72 Asset Management added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
- Point72 Asset Management's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
- Point72 Asset Management fully exited Salesforce in Q3 2020, selling an estimated $105M.
- Point72 Asset Management's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
- Point72 Asset Management opened 406 new positions and closed 288 in Q3 2020.
- Point72 Asset Management's portfolio value rose 27% quarter-over-quarter to $19.5B.
Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.